Lexology January 23, 2025
Holland & Knight LLP

Highlights

  • The U.S. Drug Enforcement Agency (DEA) recently issued three new rules making permanent multiple COVID-era telemedicine flexibilities, as well as adopting associated patient protections.
  • The Expansion of Buprenorphine Treatment rule seeks to ensure accessible treatment for opioid use disorder (OUD) while also protecting against the improper distribution of this medication.
  • The Special Registrations for Telemedicine and Limited State Telemedicine Registrations rule aims for more comprehensive prescription of certain controlled medications while also ensuring that practitioners and platforms are properly vetted to process such prescriptions.
  • The Continuity of Care via Telemedicine for Veterans Affairs Patients rule ensures that veterans continue to have access to medications even if their current U.S. Department of Veterans Affairs (VA) practitioner did not conduct...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, Govt Agencies, Provider, Technology, Telehealth
Related Articles:
Providing Interstate Telehealth Abortion Services to Patients in Restrictive States
Iris Telehealth Rolls Out Layoffs Just After Acquiring innovaTel
Congress hesitates on long-term telemedicine expansion admid advocacy push
12K ED visits averted: NYC Health + Hospitals eases overcrowding with telehealth
DEA and HHS propose telemedicine special registration and finalize buprenorphine telemedicine prescribing rules

Share This Article